GLF
INBX icon

Groupe la Francaise’s Inhibrx INBX Stock Holding History

Groupe la Francaise’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,636
Closed -$1.24M – 496
2025
Q4 		$1.24M Sell
15,636
-31,698
-67% -$2.16M 0.02% 267
2025
Q3 		$1.59M Sell
47,334
-28,598
-38% -$704K 0.02% 266
2025
Q2 		$1.08M Hold
75,932
– – 0.02% 259
2025
Q1 		$1.06M Buy
+75,932
New +$1.03M 0.02% 262

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Groupe la Francaise's INBX Position: Q1 2026 in Review

Groupe la Francaise sold out of Inhibrx (INBX) in Q1 2026, closing a stake of 15,636 shares — an estimated $1.24M sold.

Groupe la Francaise first reported a position in INBX in Q1 2025 and held it in 4 quarters. The position peaked at $1.59M in Q3 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Groupe la Francaise reported no remaining Inhibrx position as of Q1 2026 after selling out during the quarter.
  • Groupe la Francaise sold 15,636 Inhibrx shares in Q1 2026, an estimated $1.24M.
  • Groupe la Francaise first reported a position in Inhibrx in Q1 2025 and held it in 4 quarters.
  • Groupe la Francaise's Inhibrx position peaked at $1.59M in Q3 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.